Retrieve available abstracts of 42 articles: HTML format
Single Articles
April 2025
SPAGNOL G, Trease A, Zheng L, Sobota S, et al Cx45 regulation by kinases and impact of expression in heart failure.
J Mol Cell Cardiol. 2025;203:91-105. PubMedAbstract available
MCLENDON JM, Zhang X, Stein CS, Baehr LM, et al Gain and loss of the centrosomal protein taxilin-beta influences cardiac
proteostasis and stress.
J Mol Cell Cardiol. 2025;201:56-69. PubMedAbstract available
SMOLGOVSKY S, Bayer AL, Aronovitz M, Vanni KMM, et al Experimental pressure overload induces a cardiac neoantigen specific humoral
immune response.
J Mol Cell Cardiol. 2025;201:87-93. PubMedAbstract available
March 2025
ROBERTS TD, Hutchinson DS, Wootten D, De Blasio MJ, et al Advances in incretin therapies for targeting cardiovascular disease in diabetes.
J Mol Cell Cardiol. 2025;202:102-115. PubMedAbstract available
CHEN Z, Zhong M, Lin Y, Zhang W, et al METTL7B-induced histone lactylation prevents heart failure by ameliorating
cardiac remodelling.
J Mol Cell Cardiol. 2025 Mar 9:S0022-2828(25)00046. PubMedAbstract available
February 2025
GUAN J, Fefelova N, Zhai P, Ikeda Y, et al Dual inhibition of Mst1 and Mst2 exacerbates cardiac dysfunction during pressure
overload stress in mice.
J Mol Cell Cardiol. 2025;199:133-136. PubMedAbstract available
January 2025
SHABANI P, Dong F, Yun J, Shin SY, et al Does coronary microvascular dysfunction play a role in heart failure with reduced
ejection fraction?
J Mol Cell Cardiol. 2025 Jan 28:S0022-2828(25)00007. PubMedAbstract available
December 2024
KASS DA Assessing and interpreting diastolic function in animal models of heart disease.
J Mol Cell Cardiol. 2024;197:1-4. PubMedAbstract available
November 2024
KATTIH B, Fischer A, Muhly-Reinholz M, Tombor L, et al Inhibition of miR-92a normalizes vascular gene expression and prevents diastolic
dysfunction in heart failure with preserved ejection fraction.
J Mol Cell Cardiol. 2024 Nov 24:S0022-2828(24)00194. PubMedAbstract available
FU J, Li L, Chen L, Su C, et al Corrigendum to "PGE2 protects against heart failure through inhibiting TGF-beta1
synthesis in cardiomyocytes and crosstalk between TGF-beta1 and GRK2" [Journal of
Molecular and Cellular Cardiology. 172(2022) 63-77].
J Mol Cell Cardiol. 2024 Nov 22:S0022-2828(24)00191. PubMed
ABBAS N, Bentele M, Waleczek FJG, Fuchs M, et al Ex vivo modelling of cardiac injury identifies ferroptosis-related pathways as a
potential therapeutic avenue for translational medicine.
J Mol Cell Cardiol. 2024;196:125-140. PubMedAbstract available
ZERVOU S, McAndrew DJ, Lake HA, Kuznecova E, et al Cardiac function and energetics in mice with combined genetic augmentation of
creatine and creatine kinase activity.
J Mol Cell Cardiol. 2024;196:105-114. PubMedAbstract available
October 2024
JANI VP, Koleini N, Fenwick AJ, Sharp TE, et al Cardiomyocyte myofilament function in common animal models of heart failure with
preserved ejection fraction.
J Mol Cell Cardiol. 2024 Oct 18:S0022-2828(24)00166. PubMedAbstract available
BEITO M, Taegtmeyer H Metabolic cycles: A unifying concept for energy transfer in the heart.
J Mol Cell Cardiol. 2024;195:103-109. PubMedAbstract available
FAN D, Wu R Mechanisms of the septic heart: From inflammatory response to myocardial edema.
J Mol Cell Cardiol. 2024;195:73-82. PubMedAbstract available
KAPLAN AD, Boyman L, Ward CW, Lederer WJ, et al Ryanodine receptor stabilization therapy suppresses Ca(2+)- based arrhythmias in
a novel model of metabolic HFpEF.
J Mol Cell Cardiol. 2024;195:68-72. PubMedAbstract available
August 2024
WALKER MA, Tian R NAD metabolism and heart failure: Mechanisms and therapeutic potentials.
J Mol Cell Cardiol. 2024;195:45-54. PubMedAbstract available
July 2024
CANTRELL AC, Besanson J, Williams Q, Hoang N, et al Ferrostatin-1 specifically targets mitochondrial iron-sulfur clusters and
aconitase to improve cardiac function in Sirtuin 3 cardiomyocyte knockout mice.
J Mol Cell Cardiol. 2024;192:36-47. PubMedAbstract available
LAHIRI SK, Lu J, Aguilar-Sanchez Y, Li H, et al Targeting Calpain-2-mediated Junctophilin-2 cleavage delays heart failure
progression following myocardial infarction.
J Mol Cell Cardiol. 2024 Jul 1:S0022-2828(24)00108. PubMedAbstract available
April 2024
CHOKSEY A, Carter RD, Thackray BD, Ball V, et al AICAR confers prophylactic cardioprotection in doxorubicin-induced heart failure
in rats.
J Mol Cell Cardiol. 2024;191:12-22. PubMedAbstract available
March 2024
NGUYEN T, Rosa-Garrido M, Sadek H, Garry DJ, et al Promoting cardiomyocyte proliferation for myocardial regeneration in large
mammals.
J Mol Cell Cardiol. 2024;188:52-60. PubMedAbstract available
February 2024
ANTIPENKO S, Mayfield N, Jinno M, Gunzer M, et al Neutrophils are indispensable for adverse cardiac remodeling in heart failure.
J Mol Cell Cardiol. 2024;189:1-11. PubMedAbstract available
SOMA Y, Tani H, Morita-Umei Y, Kishino Y, et al Pluripotent stem cell-based cardiac regenerative therapy for heart failure.
J Mol Cell Cardiol. 2024;187:90-100. PubMedAbstract available
SAKAMOTO T, Kelly DP Cardiac maturation.
J Mol Cell Cardiol. 2024;187:38-50. PubMedAbstract available
January 2024
SHI L, Li X, Zhang M, Qin C, et al Downregulation of Wtap causes dilated cardiomyopathy and heart failure.
J Mol Cell Cardiol. 2024 Jan 13:S0022-2828(24)00002. PubMedAbstract available
SHINTANI Y, Fukushima S, Varela-Carver A, Lee J, et al Corrigendum to "Donor cell-type specific paracrine effects of cell
transplantation for post-infarction heart failure" [J Mol Cell Cardiol 47 (2009)
288-295].
J Mol Cell Cardiol. 2024 Jan 10:S0022-2828(24)00001. PubMed
CHU Y, Hua Y, He L, He J, et al beta-hydroxybutyrate administered at reperfusion reduces infarct size and preserves
cardiac function by improving mitochondrial function through autophagy in male
mice.
J Mol Cell Cardiol. 2024;186:31-44. PubMedAbstract available
November 2023
MANGIONE MC, Wen J, Cao DJ Mechanistic target of rapamycin in regulating macrophage function in inflammatory
cardiovascular diseases.
J Mol Cell Cardiol. 2023;186:111-124. PubMedAbstract available
CHEN S, Wang K, Wang J, Chen X, et al Profiling cardiomyocytes at single cell resolution reveals COX7B could be a
potential target for attenuating heart failure in cardiac hypertrophy.
J Mol Cell Cardiol. 2023;186:45-56. PubMedAbstract available
October 2023
WADDELL HMM, Mereacre V, Alvarado FJ, Munro ML, et al Clustering properties of the cardiac ryanodine receptor in health and heart
failure.
J Mol Cell Cardiol. 2023;185:38-49. PubMedAbstract available
ZHAO C, Jiang X, Peng L, Zhang Y, et al Glimepiride, a novel soluble epoxide hydrolase inhibitor, protects against heart
failure via increasing epoxyeicosatrienoic acids.
J Mol Cell Cardiol. 2023;185:13-25. PubMedAbstract available
MENASCHE P Human PSC-derived cardiac cells and their products: therapies for cardiac repair.
J Mol Cell Cardiol. 2023;183:14-21. PubMedAbstract available
September 2023
LIU Z, Liu Z, Xu X, Zhou Y, et al Role of ventrolateral part of ventromedial hypothalamus in post-myocardial
infarction cardiac dysfunction induced by sympathetic nervous system.
J Mol Cell Cardiol. 2023 Sep 30:S0022-2828(23)00154. PubMedAbstract available
PEZHOUMAN A, Nguyen NB, Kay M, Kanjilal B, et al Cardiac regeneration - Past advancements, current challenges, and future
directions.
J Mol Cell Cardiol. 2023;182:75-85. PubMedAbstract available
August 2023
KMIETCZYK V, Oelschlager J, Gupta P, Varma E, et al Ythdf2 regulates cardiac remodeling through its mRNA target transcripts.
J Mol Cell Cardiol. 2023;181:57-66. PubMedAbstract available
July 2023
KOBAYASHI S, Yamamoto T, Yano M RyR2-stabilization therapy with dantrolene against left ventricular remodeling
and lethal arrhythmia in heart failure.
J Mol Cell Cardiol. 2023 Jul 5:S0022-2828(23)00108. PubMed
June 2023
MONTANES-AGUDO P, Pinto YM, Creemers EE Splicing factors in the heart: Uncovering shared and unique targets.
J Mol Cell Cardiol. 2023;179:72-79. PubMedAbstract available
May 2023
YAMADA Y, Sadahiro T, Ieda M Development of direct cardiac reprogramming for clinical applications.
J Mol Cell Cardiol. 2023;178:1-8. PubMedAbstract available
April 2023
MEHDIPOUR M, Park S, Huang GN Unlocking cardiomyocyte renewal potential for myocardial regeneration therapy.
J Mol Cell Cardiol. 2023;177:9-20. PubMedAbstract available
LI R, Xiang C, Li Y, Nie Y, et al Targeting immunoregulation for cardiac regeneration.
J Mol Cell Cardiol. 2023;177:1-8. PubMedAbstract available
March 2023
GARRY GA, Olson EN Reprogramming of cardiac cell fate as a therapeutic strategy for ischemic heart
disease.
J Mol Cell Cardiol. 2023 Mar 28:S0022-2828(23)00058. PubMedAbstract available
FUJII S, Kobayashi S, Chang Y, Nawata J, et al RyR2-targeting therapy prevents left ventricular remodeling and ventricular
tachycardia in post-infarction heart failure.
J Mol Cell Cardiol. 2023 Mar 22:S0022-2828(23)00052. PubMedAbstract available